These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1728654)

  • 1. Involvement of pharmacy faculty in the development of policies for pharmaceutical sales representatives.
    Bucci KK; Frey KA
    J Fam Pract; 1992 Jan; 34(1):49-52. PubMed ID: 1728654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.
    Mahood S; Zagozeski C; Bradel T; Lawrence K
    Can Fam Physician; 1997 Nov; 43():1947-51. PubMed ID: 9386881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policies regulating the activities of pharmaceutical representatives in residency programs.
    Brotzman GL; Mark DH
    J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey of research requirements for family practice residents and faculty.
    Neale AV
    Fam Med; 2002 Apr; 34(4):262-7. PubMed ID: 12017140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical therapy education in family practice residency programs.
    Maira ML; Patton DD; Purvis JR
    Fam Med; 1994 Oct; 26(9):576-8. PubMed ID: 7843507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors.
    Lichstein PR; Turner RC; O'Brien K
    Arch Intern Med; 1992 May; 152(5):1009-13. PubMed ID: 1580704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical services in family practice medical residency training programs.
    Bendayan R; Robinson JD; Stewart RB
    Am J Hosp Pharm; 1983 Feb; 40(2):274-7. PubMed ID: 6829581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National survey of hospital policies on pharmaceutical sales representatives' activities.
    Thomas J
    Am J Hosp Pharm; 1987 Jun; 44(6):1334-40. PubMed ID: 3618609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirituality and health care education in family medicine residency programs.
    King DE; Crisp J
    Fam Med; 2005 Jun; 37(6):399-403. PubMed ID: 15933911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical industry support and residency education: a survey of internal medicine program directors.
    Loertscher LL; Halvorsen AJ; Beasley BW; Holmboe ES; Kolars JC; McDonald FS
    Arch Intern Med; 2010 Feb; 170(4):356-62. PubMed ID: 20177039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of occupational medicine training among US family medicine residency programs.
    Michas MG; Iacono CU
    Fam Med; 2008 Feb; 40(2):102-6. PubMed ID: 18247175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teaching information mastery: evaluating information provided by pharmaceutical representatives.
    Shaughnessy AF; Slawson DC; Bennett JH
    Fam Med; 1995 Oct; 27(9):581-5. PubMed ID: 8829983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who teaches residents about the prevention and treatment of substance use disorders? A national survey.
    Fleming MF; Manwell LB; Kraus M; Isaacson JH; Kahn R; Stauffacher EA
    J Fam Pract; 1999 Sep; 48(9):725-9. PubMed ID: 10498080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suggested guidelines for pharmacotherapy curricula in family medicine residency training: recommendations from the Society of Teachers of Family Medicine Group on Pharmacotherapy.
    Bazaldua O; Ables AZ; Dickerson LM; Hansen L; Harris I; Hoehns J; Jackson E; Kraus C; Mayville H; Saseen JJ;
    Fam Med; 2005 Feb; 37(2):99-104. PubMed ID: 15690249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fourth-year chief resident position in family practice training, 1987-1992.
    Sand R
    Fam Med; 1994 May; 26(5):299-302. PubMed ID: 8050648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.